Glecaprevir/pibrentasvir+sofosbuvir for post-liver transplant recurrent hepatitis C virus treatment
摘要
Glecaprevir/pibrentasvir in combination with sofosbuvir may serve as a safe and effective option for treatment of recurrent hepatitis C virus post-liver transplant in patients who previously failed direct-acting antivirals.
-
1Kazuto Tajiri,Hiroyuki Ito,Kengo Kawai,Yoshiro Kashii,Yuka Hayashi,Aiko Murayama,Masami Minemura,Terumi Takahara,Yukihiro Shimizu,Ichiro Yasuda.Direct-acting antivirals for hepatitis C virus-infected patients with hepatocellular carcinoma[J].World Journal of Hepatology,2022,14(6):1190-1199.
-
2Aisha Elsharkawy,Reham Samir,Mohamed El-Kassas.Fibrosis regression following hepatitis C antiviral therapy[J].World Journal of Hepatology,2022,14(6):1120-1130.
-
3MichałBrzdęk,Dorota Zarębska-Michaluk,Federica Invernizzi,Marta Cilla,Krystyna Dobrowolska,Robert Flisiak.Decade of optimizing therapy with direct-acting antiviral drugs and the changing profile of patients with chronic hepatitis C[J].World Journal of Gastroenterology,2023,29(6):949-966. 被引量：1
-
4Dorota Zarębska-Michaluk,Michal Brzdęk,Jerzy Jaroszewicz,Magdalena Tudrujek-Zdunek,Beata Lorenc,Jakub Klapaczyński,Włodzimierz Mazur,Adam Kazek,Marek Sitko,Hanna Berak,Justyna Janocha-Litwin,Dorota Dybowska,Łukasz Supronowicz,Rafal Krygier,Jolanta Citko,Anna Piekarska,Robert Flisiak.Best therapy for the easiest to treat hepatitis C virus genotype 1binfected patients[J].World Journal of Gastroenterology,2022,28(45):6380-6396.
-
5Xiaohui Zhang,Yingying Jiang,Shaobin Li,Dandan Bian,Mei Liu,Ming Kong,Yu Chen,Zhongping Duan,Sujun Zheng.Direct-acting Antiviral-induced Transient Recovery of NK Cells in Early-stage Treatment of Chronic Hepatitis C Patients[J].Journal of Clinical and Translational Hepatology,2022,10(6):1117-1124.
-
6Iman Ibrahim Salama,Hala M Raslan,Ghada A Abdel-Latif,Somaia I Salama,Samia M Sami,Fatma A Shaaban,Aida M Abdelmohsen,Walaa A Fouad.Impact of direct-acting antiviral regimens on hepatic and extrahepatic manifestations of hepatitis C virus infection[J].World Journal of Hepatology,2022,14(6):1053-1073.
-
7Elettra Merola,Elisa Menotti,Giovanna Branz,Andrea Michielan,Sonia Seligmann,Annora Ratti,Flora Agugiaro,Luisa Moser,Giovanni Vettori,Anna Franceschini,William Mantovani,Riccardo Pertile,Giovanni de Pretis,Cecilia Pravadelli.Hepatitis C virus burden:Treating and educating people without prejudice[J].World Journal of Hepatology,2022,14(7):1495-1503. 被引量：1
-
8Qing Yuan,Shanjuan Hong,Gregory Leya,Eve Roth,Georgios Tsoulfas,WW Williams,Joren C Madsen,Nahel Elias.Analysis of the effects of donor and recipient hepatitis C infection on kidney transplant outcomes in the United States[J].World Journal of Transplantation,2023,13(2):44-57.
-
9钟思琦,徐和,姜良坤,范晶华.《母胎医学会(SMFM)咨询系列#56:妊娠期丙型肝炎(更新版)-替代2017年11月第43号文件》摘译[J].中国热带医学,2022,22(12):1211-1214.
-
10Yong-Fang Kuo,Paul Kwo,Robert J Wong,Ashwani K.Singal.Impact of COVID-19 on Liver Transplant Activity in the USA: Variation by Etiology and Cirrhosis Complications[J].Journal of Clinical and Translational Hepatology,2023,11(1):130-135.
